Published in J Investig Med on December 01, 2012
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation (2014) 0.98
Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One (2014) 0.93
The Association Between Subcutaneous Fat Density and the Propensity to Store Fat Viscerally. J Clin Endocrinol Metab (2015) 0.89
Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity. Arthritis Rheumatol (2017) 0.81
Adipose tissue fibrosis. World J Diabetes (2015) 0.79
Obesity: An Immunometabolic Perspective. Front Endocrinol (Lausanne) (2016) 0.76
High-fat diet promotes mammary gland myofibroblast differentiation through miR-140 downregulation. Mol Cell Biol (2016) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Inflammation and metabolic disorders. Nature (2006) 33.33
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol (2009) 11.63
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 8.15
Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science (2011) 6.83
Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol (2004) 6.75
Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest (2008) 6.60
Adipose tissue remodeling and obesity. J Clin Invest (2011) 6.12
Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes (2007) 6.08
IL-13 effector functions. Annu Rev Immunol (2001) 5.51
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2005) 5.13
Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2008) 4.75
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
The IL-1 family: regulators of immunity. Nat Rev Immunol (2010) 4.65
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest (1999) 4.22
Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 3.96
IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol (2000) 3.03
Impaired development of Th2 cells in IL-13-deficient mice. Immunity (1998) 2.68
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A (1993) 2.58
Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A (1996) 2.57
The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol (1998) 2.57
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol (2004) 2.47
Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes (2010) 2.46
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A (2009) 1.97
Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes (1999) 1.94
Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res (1996) 1.77
The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology (2008) 1.68
cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem (1996) 1.68
Infectious disease, the innate immune response, and fibrosis. J Clin Invest (2007) 1.68
Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal (2008) 1.57
Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem (1996) 1.43
Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol (2008) 1.41
Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A (2007) 1.39
Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol (2001) 1.35
High-fat diet-induced adipocyte cell death occurs through a cyclophilin D intrinsic signaling pathway independent of adipose tissue inflammation. Diabetes (2011) 1.22
Loss of autophagy in hypothalamic POMC neurons impairs lipolysis. EMBO Rep (2012) 1.17
IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol (2005) 1.12
Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice. Mol Ther (2007) 0.92
Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation. Diabetes (2013) 0.80
Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes (2004) 0.79